Search results for "Percutaneous"

showing 10 items of 471 documents

Temporal retrogasserian resection of trigeminal root versus controlled elective percutaneous electrocoagulation of the ganglion of gasser in the trea…

1972

In his experience with 531 surgical procedures for the relief of trigeminal neuralgia between 1955 to 1970, the author developed a strong preference for the percutaneous electro-coagulation of the gasserian ganglion. Although the method was repeatedly modified in the early years, a standardized technique of controlled, selective and fractional coagulation in the semiawake state of neurolept-anaesthesia was used since 1963 in 183 of his 311 patients, treated in this manner. The advantages of the method, particularly in comparison to open intracranial root sections, are: Minimal operative risk, control of operative effect during the operation, small sensibility deficit, low rate of complicati…

Malemedicine.medical_specialtyPercutaneousmedicine.medical_treatmentmedia_common.quotation_subjectElectrocoagulationStereotaxic TechniquesThalamusTrigeminal neuralgiaMesencephalonmedicineElectrocoagulationMethodsHumansTrigeminal Nervemedia_commonNeuroradiologyMedulla Oblongatamedicine.diagnostic_testbusiness.industryConvalescenceInterventional radiologyTrigeminal Neuralgiamedicine.diseaseSurgeryGanglionmedicine.anatomical_structureEvaluation Studies as TopicAnesthesiaSurgeryNeurology (clinical)NeurosurgerybusinessCraniotomyActa neurochirurgica
researchProduct

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

2018

Aims: The clinical value of percutaneous coronary intervention (PCI) for chronic coronary total occlusions (CTOs) is not established by randomized trials. This study should compare the benefit of PCI vs. optimal medical therapy (OMT) on the health status in patients with at least one CTO.Method and results: Three hundred and ninety-six patients were enrolled in a prospective randomized, multicentre, open-label, and controlled clinical trial to compare the treatment by PCI with OMT with a 2:1 randomization ratio. The primary endpoint was the change in health status assessed by the Seattle angina questionnaire (SAQ) between baseline and 12 months follow-up. Fifty-two percent of patients have …

Malemedicine.medical_specialtyRandomizationmedicine.medical_treatmentAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyAngina Pectorislaw.inventionAngina03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRandomized controlled triallawInternal medicinemedicineClinical endpointHumansPercutaneous transluminal interventioncardiovascular diseases030212 general & internal medicineMyocardial infarctionOptimal medical therapyAgedNitratesbusiness.industryAngina PectoriPercutaneous coronary interventionAngiotensin-Converting Enzyme InhibitorMiddle Agedmedicine.diseaseClinical trialCoronary OcclusionChronic coronary occlusion; EQ-5D; Optimal medical therapy; Percutaneous transluminal intervention; Seattle angina questionnaire; Cardiology and Cardiovascular MedicineConventional PCIChronic DiseaseChronic coronary occlusionQuality of LifeSeattle angina questionnaireFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitors
researchProduct

Programmed death-1 (PD-1): A novel mechanism for understanding the acute immune deregulation in ST-segment elevation myocardial infarction

2014

Malemedicine.medical_specialtySwinemedicine.medical_treatmentProgrammed Cell Death 1 ReceptorMyocardial InfarctionPercutaneous Coronary InterventionImmune systemInternal medicinemedicineAnimalsHumansST segmentProspective StudiesMyocardial infarctionAgedMechanism (biology)business.industryPercutaneous coronary interventionMiddle Agedmedicine.diseaseProgrammed Cell Death 1 ReceptorCardiologyFemaleProgrammed death 1ComprehensionCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention.

2017

Malemedicine.medical_specialtyTicagrelorPrasugrelAdenosinemedicine.medical_treatmentTreatment outcomeMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionInternal medicinemedicineHumansIn patient030212 general & internal medicineNon-ST Elevated Myocardial InfarctionAgedRetrospective Studiesbusiness.industryPercutaneous coronary interventionRetrospective cohort studyGeneral MedicineMiddle AgedNSTEMITreatment OutcomeEmergency medicineCardiologyPurinergic P2Y Receptor AntagonistsObservational studyFemalebusinessCardiology and Cardiovascular MedicineTicagrelorPrasugrelPrasugrel Hydrochloridemedicine.drugJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings

2006

Background: There are several new strategies proposed to improve the outcome of patients with ST-elevation myocardial infarction (STEMI). One approach is the resurgent use of facilitated percutaneous coronary interventions (PCI). Until recently, deciding whether immediate PCI after combined treatment (facilitated PCI) is more appropriate than delayed PCI (short time) has not been investigated. The aim of this study, therefore, was to investigate the outcomes in patients initially successfully treated pharmacologically and immediate PCI < 2 hr, and in patients initially successfully treated with pharmacological therapy and with delayed PCI (12–72 h). Methods: 451 reperfused STEMI patients, a…

Malemedicine.medical_specialtyTiclopidineTime Factorsmedicine.medical_treatmentMyocardial InfarctionFacilitated Percutaneous Coronary InterventionPlatelet Glycoprotein GPIIb-IIIa ComplexGIIb/IIIa inhibitorDelayed Percutaneous Coronary InterventionsInternal medicineAngioplastymedicineAbciximabAcute myocardial InfarctionHumanscardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedbusiness.industryAnticoagulantsPercutaneous coronary interventionHematologyTirofibanMiddle AgedClopidogrelmedicine.diseaseCombined Modality TherapyClopidogrelsurgical procedures operativeTissue Plasminogen ActivatorConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinesstherapeuticsCombined therapyPlatelet Aggregation InhibitorsTIMIFollow-Up Studiesmedicine.drugJournal of Thrombosis and Thrombolysis
researchProduct

Pre-operative Diagnosis of Silent Coronary Ischaemia May Reduce Post-operative Death and Myocardial Infarction and Improve Survival of Patients Under…

2019

Objective Patients undergoing peripheral vascular surgery have increased risk of death and myocardial infarction (MI), which may be due to unsuspected (silent) coronary ischaemia. The aim was to determine whether pre-operative diagnosis of silent ischaemia using coronary computed tomography (CT) derived fractional flow reserve (FFRCT) can facilitate multidisciplinary care to reduce post-operative death and MI, and improve survival. Methods This was a single centre prospective study with historic controls. Patients with no cardiac symptoms undergoing lower extremity surgical revascularisation with pre-operative coronary CTA-FFRCT testing were compared with historic controls with standard pre…

Malemedicine.medical_specialtyTime FactorsComputed Tomography Angiographymedicine.medical_treatmentMyocardial InfarctionFractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematology030230 surgeryCoronary AngiographyRisk Assessment03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesProspective cohort studyAgedmedicine.diagnostic_testbusiness.industryCoronary StenosisPercutaneous coronary interventionVascular surgeryMiddle Agedmedicine.diseaseFractional Flow Reserve MyocardialStenosismedicine.anatomical_structureLower ExtremityCase-Control StudiesAngiographyAsymptomatic DiseasesCardiologySurgeryFemaleCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresArteryEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
researchProduct

Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting ste…

2008

Objectives: To investigate the long-term prognostic implications of complete versus incomplete revascularization in multivessel coronary artery disease (MVD) patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stent (DES). Background: Coronary artery bypass grafting (CABG) in patients with MVD provides better outcomes when complete revascularization is achieved. There is a paucity of data on the outcomes of complete versus incomplete revascularization of MVD patients undergoing PCI, and currently there is no data available with DES. Methods: Patients with MVD undergoing PCI with DES (sirolimus- or paclitaxel-eluting stent) were included. Comparisons of long-term o…

Malemedicine.medical_specialtyTime FactorsPaclitaxelmedicine.medical_treatmentPopulationCoronary Artery DiseaseKaplan-Meier EstimateRevascularizationRisk AssessmentCoronary artery diseaseInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingMyocardial infarctionRegistriesAngioplasty Balloon CoronaryeducationAgedProportional Hazards ModelsRetrospective StudiesSirolimuseducation.field_of_studyMultivessel diseasebusiness.industryStentPercutaneous coronary interventionCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgeryRevascularization strategy.Treatment OutcomeDrug-eluting stentCardiovascular DiseasesConventional PCICardiologyFemaleDrug-eluting stentCardiology and Cardiovascular MedicinebusinessCatheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions
researchProduct

The DETOUR procedure: no more need for conventional bypass surgery?

2018

Background Long segment occlusive disease in the superficial femoral artery remains a treatment challenge despite advances in open surgical and endovascular approaches. We report initial clinical results of an entirely new procedure to perform percutaneous femoro-popliteal bypass using the DETOUR System. First-in-human patients were performed in New Zealand from December 2013 to June 2014. After modifications to the technique and devices had significantly refined the procedure, the Detour I Trial commenced. Methods Review of initial results in the first five patients treated at a single site enrolled in IRB-approved, prospective clinical study using the DETOUR System. All patients signed in…

Malemedicine.medical_specialtyTime FactorsPercutaneousComputed Tomography AngiographyDeep veinmedicine.medical_treatmentFemoral veinConstriction PathologicFemoral artery030204 cardiovascular system & hematology030218 nuclear medicine & medical imagingBlood Vessel Prosthesis ImplantationPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRecurrenceBlood vessel prosthesismedicine.arterymedicineHumansProspective StudiesVascular PatencyAgedAged 80 and overbusiness.industryEndovascular ProceduresStentPhlebographyGeneral MedicineMiddle AgedLatviaPopliteal arteryBlood Vessel ProsthesisSurgeryFemoral ArteryTreatment Outcomemedicine.anatomical_structureBypass surgeryFemaleStentsSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Cardiovascular Surgery
researchProduct

Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propen…

2018

Objectives We sought to determine the 1-year clinical follow-up in patients treated with the thin strut (71 μm) bioabsorbable polymer-coated sirolimus-eluting stent (BP-SES) vs durable coating everolimus eluting stent (DP-EES) in daily clinical routine. Background Presence of durable polymers may be associated with late/very late stent thrombosis occurrence and the need for prolonged dual antiplatelet therapy. Bioabsorbable polymers may facilitate stent healing, thus enhancing clinical safety. Methods Interventional Cardiology Network Registry is a prospective, multicenter, observational registry of 21,400 consecutive patients treated with PCI since 2010. We analyzed 4,670 patients treated …

Malemedicine.medical_specialtyTime FactorsPolymersmedicine.medical_treatmentCoronary Artery Disease030204 cardiovascular system & hematologyProsthesis DesignRisk Assessment03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineRisk FactorsAbsorbable ImplantsmedicineHumansRadiology Nuclear Medicine and imagingEverolimusRegistries030212 general & internal medicineMyocardial infarctionAngioplasty Balloon CoronaryPropensity ScoreAgedRetrospective StudiesSirolimusInterventional cardiologybusiness.industryStentPercutaneous coronary interventionCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeBioresorbable polymerSirolimusConventional PCIPropensity score matchingFemaleObservational studyPolandCardiology and Cardiovascular Medicinebusinessmedicine.drugCatheterization and Cardiovascular Interventions
researchProduct

Optical Coherence Tomography Versus Intravascular Ultrasound to Evaluate Coronary Artery Disease and Percutaneous Coronary Intervention

2013

ObjectivesWe compared intravascular ultrasound (IVUS) and 2 different generations of optical coherence tomography (OCT)—time-domain OCT (TD-OCT) and frequency-domain OCT (FD-OCT)—for the assessment of coronary disease and percutaneous coronary intervention (PCI) using stents.BackgroundOCT is a promising light-based intravascular imaging modality with higher resolution than IVUS. However, the paucity of data on OCT image quantification has limited its application in clinical practice.MethodsA total of 227 matched OCT and IVUS pull backs were studied. One hundred FD-OCT and IVUS pull backs in nonstented (n = 56) and stented (n = 44) vessels were compared. Additionally, 127 matched TD-OCT and …

Malemedicine.medical_specialtyTime Factorsgenetic structuresmedicine.medical_treatmentTreatment outcomeSeverity of Illness Indexintravascular ultrasoundCoronary RestenosisCoronary artery diseaseOptical coherence tomographyPredictive Value of TestsNeointimaIntravascular ultrasoundmedicineHumanscardiovascular diseasesUltrasonography InterventionalAgedCell ProliferationAnalysis of VarianceHyperplasiaoptical coherence tomographymedicine.diagnostic_testbusiness.industrypercutaneous coronary interventionCoronary StenosisPercutaneous coronary interventionMiddle Agedequipment and suppliesmedicine.diseaseCoronary Vesselseye diseasesTreatment Outcomesurgical procedures operativeLinear ModelsFemaleStentssense organsTomographyRadiologyUltrasonographybusinessCardiology and Cardiovascular MedicineTomography Optical CoherenceJACC: Cardiovascular Interventions
researchProduct